Episodios

  • How Optoceutics Is Exploring the Power of Light Therapy Beyond Mood Enhancement

    How Optoceutics Is Exploring the Power of Light Therapy Beyond Mood Enhancement
    Mar 14 2025
    We all know light therapy can brighten our mood, especially for those battling depression or seasonal affective disorder. But what if light could do so much more? In this week's episode of StartUp Health NOW, we dive deep into the revolutionary work of StartUp Health community member Mai Nguyen, PhD, CEO & Co-founder of Optoceutics. Forget what you think you know about light therapy. Nguyen and her team are pioneering a new frontier, demonstrating how precisely delivered light, through the eyes, can actually reprogram brain waves. This isn't just about mood enhancement; it's about potentially slowing the progression of neurodegenerative diseases like Alzheimer's. Join us for a fascinating conversation with Nguyen, a Berkeley researcher turned entrepreneur, as she discusses her groundbreaking device, currently marketed as a wellness tool, but with profound clinical aspirations. Discover how her collaboration with engineers in Copenhagen has led to a novel technology that's already making waves. This episode will challenge your perception of the lights around you and illuminate the future of brain health. Get ready to have your mind blown! Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto
  • Early Detection, Better Outcomes: Transforming Alzheimer’s Diagnosis with CxPM

    Early Detection, Better Outcomes: Transforming Alzheimer’s Diagnosis with CxPM
    Mar 6 2025
    Imagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer’s. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer's research and therapies emerge, making early detection more vital than ever. That’s where Cx Precision Medicine comes in. In this episode, we sit down with Sid O’Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp Health Alzheimer's Moonshot Community working to revolutionize early cognitive screening with a simple blood test. Their innovative diagnostic tool is designed to detect neurodegenerative diseases earlier, ensuring patients get the right care at the right time. O’Bryant's extensive research, now commercialized by Altman's leadership, offers a powerful tool for personalized care, enabling earlier, more accurate diagnoses of neurodegenerative diseases. We'll dive into their unique journeys, the science behind their innovative blood test, and how it's poised to transform patient care. Discover how Cx Precision Medicine is empowering patients to get the right care at the right time, streamlining the diagnostic process and ultimately, improving lives. Join us as we explore the future of Alzheimer's detection and the hope it brings. Let's get into it! Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto
  • Can Light Therapy Slow Alzheimer’s? The Science of Photobiomodulation with Guillaume Blivet of REGEnLIFE

    Can Light Therapy Slow Alzheimer’s? The Science of Photobiomodulation with Guillaume Blivet of REGEnLIFE
    Feb 28 2025
    On this episode of StartUp Health NOW, we learn about the power of photobiomodulation, a light therapy that promotes healing at the cellular level. From treating seasonal affective disorder to wound healing, light therapy's applications are expanding. We're joined by Guillaume Blivet of REGEnLIFE, a member of the StartUp Health community who is pioneering research into using photobiomodulation to address Alzheimer's disease. Learn how their unique approach, targeting both the brain and gut, shows promise in reducing inflammation and improving cellular health. We discuss the science, the promising early results, and the potential of this groundbreaking approach. Unveiling Photobiomodulation: Dive into the science of photobiomodulation, a cutting-edge light therapy that stimulates cellular healing at the molecular level. Explore how specific wavelengths of red and near-infrared light can trigger biological responses, reducing inflammation and promoting cellular health. Beyond Traditional Light Therapy: Discover how researchers are pushing the boundaries of light therapy beyond seasonal affective disorder and dermatology. Learn about innovative applications of photobiomodulation for internal therapeutic benefits. REGEnLIFE's Revolutionary Approach: Meet Guillaume Blivet, co-founder of REGEnLIFE, and his team's pioneering work in applying photobiomodulation to combat Alzheimer's disease. Explore their unique strategy of targeting both the brain and the gut simultaneously, leveraging the crucial gut-brain connection. Learn about the animal studies that have shown promising results. Innovation in Alzheimer's Treatment: Understand how REGEnLIFE's photobiomodulation therapy aims to slow the progression of Alzheimer's by reducing neuroinflammation and enhancing cellular function. Hear about the ongoing human trials in France and the potential for this non-invasive, safe treatment to transform Alzheimer's care. Tune in now as we learn how targeting the gut-brain connection with specific wavelengths of light could offer new hope for patients. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto
  • How Veravas Brings Clarity to Diagnostics by Cleaning Samples

    How Veravas Brings Clarity to Diagnostics by Cleaning Samples
    Feb 21 2025
    When your health is on the line, accurate diagnostics are crucial. But many blood tests suffer from false positives, false negatives, and frustrating gray areas. In this episode of StartUp Health NOW, host Logan Plaster sits down with John Forrest, CEO & Co-founder of Veravas, a member of the StartUp Health community, to discuss their groundbreaking solution. VeraBIND: Learn how Veravas' patented technology cleans blood samples to remove impurities, dramatically increasing diagnostic accuracy and eliminating ambiguous results. Transforming Alzheimer's Detection: Find out how VeraBIND results in a test with a single result that says yes, you have the disease, or no, you don’t. Beyond Blood: Explore the potential of VeraBIND to transform diagnostics for a wide range of diseases, even using saliva samples – which are much easier for older patients to manage on a regular basis. The Future: Hear Forrest's insights on the challenges and opportunities in the health tech industry and how Veravas is poised to make a significant impact. Tune in for the conversation and learn how Veravas is turning the tide on diagnostic uncertainty. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    31 m
  • DatosX Boosts Innovation & Product-Market Fit Through Faster Tech Trials

    DatosX Boosts Innovation & Product-Market Fit Through Faster Tech Trials
    Feb 14 2025
    Are health tech founders building what the market actually needs? At StartUp Health, we see firsthand their biggest challenge: achieving product-market fit. But it's more than just market alignment. Investor Robert Garber of 7wireVentures calls it "contract-market fit"—proof that people will pay. This week, we talk with Robin Roberts, CEO & Founder of DatosX, a company in the StartUp Health community that is helping digital health startups achieve just that. The Problem: Many early-stage health companies struggle with product-market fit. They may be building amazing technology, but the market isn't ready. The Solution: DatosX is a two-sided marketplace connecting health tech buyers (like hospitals) with startups. This enables: Pre-validation of purchases by hospitals. Creation of buyable products by startups. The Insight: This unique position gives Roberts a front-row seat to what hospitals really want (hint: it involves physician efficiency) and where startups often miss the mark. The Opportunity: We explore these critical trends and discover the opportunities for savvy startups in 2025. Listen in as Roberts shares his insights on achieving product-market fit and contract-market fit in the digital health space. The Access to Care Moonshot Community is comprised of mission-aligned founders and CEOs collaborating to accelerate breakthroughs to deliver quality care to everyone, regardless of location or income. » Meet the Access to Care Moonshot Community » Join a Health Moonshot Community Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto
  • SynchNeuro: How a Neurosurgeon Is Changing Cardiometabolic Care

    SynchNeuro: How a Neurosurgeon Is Changing Cardiometabolic Care
    Feb 7 2025
    Ever wonder where the next big breakthrough in health will come from? Sometimes, the most innovative solutions arise from the most unexpected places. This week’s podcast episode dives into the fascinating world of a neurosurgeon who's revolutionizing glucose monitoring. Join us as we explore the groundbreaking work of Dr. Casey Halpern, co-founder of SynchNeuro, who is changing cardiometabolic care via the brain. We discuss: The unexpected connection between the brain and metabolism: How a neurosurgeon specializing in Parkinson's disease came across a game-changing approach to glucose monitoring. A non-invasive CGM for everyone: Learn about SynchNeuro's innovative behind-the-ear EEG device that could make continuous glucose monitoring accessible and affordable for millions at risk of Type 2 diabetes and heart disease. From physician to founder: Dr. Halpern shares his inspiring story as a doctorpreneur, leading the double life of a medical career and leading a cutting-edge health tech startup. The future of cardiometabolic health: We explore how this new technology, combined with the rise of GLP-1 medications, could transform the way we manage and prevent diabetes and heart disease. The science behind the breakthrough: A deep dive into the research connecting brain signals to appetite and blood sugar regulation. Tune in to discover how SynchNeuro – a member of our Cardiometabolic Health Moonshot Community – is poised to reshape the landscape of cardiometabolic health and empower individuals to take control of their wellbeing. For years, chronic health problems like heart disease and Type 2 diabetes have grown, becoming some of society's biggest killers. Thankfully, there's a generation of entrepreneurs tackling the issue from every angle. In the Cardiometabolic Health Moonshot Community, mission-aligned founders and CEOs collaborate to accelerate breakthroughs in cardiometabolic disease prevention, diagnosis, monitoring, management, and cures. » Meet the Community » Join the Community Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto
  • Edamam CEO: Why Food as Medicine Has Hit a Market Tipping Point & Opportunities in the Space

    Edamam CEO: Why Food as Medicine Has Hit a Market Tipping Point & Opportunities in the Space
    Jan 31 2025
    This idea called “food as medicine” isn’t new. People have been talking for decades about how the foods we put in our body play a bigger role in preventative health and disease management than any drug or medication we could. But it’s always been on the fringe. Partly because it’s difficult to do the studies that clinically prove that foods can be as effective as medications. And second, which is related, there hasn’t been much funding for this kind of work. So, what’s changed? To answer that question, we sat down with Victor Penev, CEO & Founder of Edamam, a longtime member of the StartUp Health Community. Victor’s created what may be the world’s largest repository of food data. But he’s also a futurist with a keen eye on where the industry is heading. In our conversation Penev explains how the uptake in GLP-1s and generative AI have come together in a fascinating way that opens up new opportunities in nutrition. Importantly, it may open up new funding sources and innovative business models. On that note: StartUp Health has formally kicked off our Food as Medicine Health Moonshot Community, so if you or someone you know is a founder working in nutrition, someone with a passion to use food to make the world a healthier place, we’re accepting applications at StartUpHealth.com. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto
  • Imaginostics Is Imagining Brand New Innovative, Non-Invasive Diagnostic Solutions for Health & Disease

    Imaginostics Is Imagining Brand New Innovative, Non-Invasive Diagnostic Solutions for Health & Disease
    Jan 23 2025
    What if a single scan could not only diagnose existing health issues but also predict future problems and help prevent them? That’s the groundbreaking vision behind Imaginostics, a startup co-founded by Codi Gharagouzloo, PhD. A new member of the StartUp Health community, Imaginostics creates innovative, non-invasive diagnostic solutions using breakthrough quantitative imaging biomarkers to provide new insight in health and disease. In this episode, StartUp Health co-founder Unity Stoakes interviews Gharagouzloo during JPM Week in San Francisco to explore the science behind Imaginostics and the unique technology they’re developing to revolutionize preventative health. You’ll also hear Gharagouzloo’s fascinating founder journey, from a troublemaking youth to a physicist with a soul-deep passion for transforming healthcare. With $5M raised and an FDA breakthrough designation in hand, Imaginostics is making waves. Don’t miss this inspiring story of innovation, passion, and the pursuit of better health for all.Tune in now! Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
    Más Menos
    Menos de 1 minuto